Cleared Traditional

K213004 - Needle Free Connector

K213004 is an FDA 510(k) clearance for Needle Free Connector, manufactured by Medcaptain Life Science Co., Ltd.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 232-day FDA review.

K213004 · Medcaptain Life Science Co., Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2022
Decision
232d
Days
Class 2
Risk

K213004 is an FDA 510(k) clearance for the Needle Free Connector. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Medcaptain Life Science Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on May 10, 2022 after a review of 232 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Medcaptain Life Science Co., Ltd. devices

FDA 510(k) Submission Details - K213004

510(k) Number K213004 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 20, 2021
Decision Date May 10, 2022
Days to Decision 232 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
103d slower than avg
Panel avg: 129d · This submission: 232d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 532
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K213004.
NeutrArt
K221481 · Asset Medikal Tasarim As. · Sep 2022
Q2 Blood Administration Sets
K213846 · Quest Medical, Inc. · Jun 2022
Q2 IV Administration Sets
K213588 · Quest Medical, Inc. · Jun 2022
Infusion Sets for Single Use
K202437 · Jiangsu Suyun Medical Materials Co., Ltd. · Mar 2022
IV Administration Set
K213778 · B.Braun Medical, Inc. · Mar 2022
Microvolume Luer Access Device
K212842 · B.Braun Medical, Inc. · Jan 2022